Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insulet Corp PODD

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also... see more

Recent & Breaking News (NDAQ:PODD)

Insulet’s Programs at the American Association of Diabetes Educators Conference and Its New San Diego Innovation Center of Excellence Highlight Company’s Commitment to Innovation

Business Wire August 2, 2017

Insulet Corporation to Present at Upcoming Investor Conferences

Business Wire August 1, 2017

Insulet prendra en charge la distribution et l'assistance commerciale de son système Omnipod® en Europe

Business Wire July 20, 2017

Insulet to Assume Distribution and Commercial Support for Its Omnipod® System in Europe

Business Wire July 20, 2017

Insulet Corporation to Announce Second Quarter 2017 Financial Results on August 3, 2017

Business Wire July 13, 2017

Medical Supplies Stocks on Investors' Radar -- Endologix, Microbot Medical, ConforMIS, and Insulet

PR Newswire June 21, 2017

Insulet Presents Positive Omnipod® Horizon™ Hybrid Closed-Loop Study Results in Children

Business Wire June 12, 2017

Insulet to Preview New Clinical Data and Next Generation Omnipod® System at the American Diabetes Association’s 77th Scientific Sessions

Business Wire June 9, 2017

Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR(R)NEXT ONE BGMS and Omnipod Dash(TM) PDM

PR Newswire Asia June 8, 2017

Insulet Corporation to Present at Upcoming Investor Conference

Business Wire June 5, 2017

Insulet Appoints Bret Christensen as Chief Commercial Officer

Business Wire May 30, 2017

INSULET INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Insulet Corporation for Possible Securities Fraud - PODD

Business Wire May 26, 2017

Insulet Corporation Ranked #4 on Forbes 2017 Most Innovative Growth Companies List

Business Wire May 25, 2017

INSULET INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Insulet Corporation for Possible Securities Fraud - PODD

Business Wire May 12, 2017

Research Reports Initiation on Healthcare Stocks -- Endologix, C. R. Bard, Insulet, and Vericel

PR Newswire May 12, 2017

INSULET INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Insulet Corporation for Possible Securities Fraud - PODD

PR Newswire May 8, 2017

Insulet Reports First Quarter 2017 Financial Results

Business Wire May 8, 2017

Investor Network: Insulet Corporation to Host Earnings Call

Accesswire May 8, 2017

Robbins Arroyo LLP: Insulet Corporation (PODD) Misled Shareholders According to a Class Action

Business Wire May 2, 2017

Insulet Corporation to Announce First Quarter 2017 Financial Results on May 8, 2017

Business Wire April 7, 2017